| Specialty | GLP-1 / weight loss (compounded and brand) |
|---|---|
| Medications | Compounded semaglutide and tirzepatide (with B12/glycine); brand GLP-1s through insurance |
| Price | Compounded semaglutide, cash pay: $149 for the first 28-day cycle, then $269 month to month, or $199, $179 and $149 per cycle on 3-, 6- and 12-month terms; tirzepatide $339 month to month and $199 on 12 months (joinfound.com, read November 20, 2026). |
| Read status | Re-read November 20, 2026 |
| Score | 75/100 · v4.1 score from pages read November 20, 2026 |
| Website | joinfound.com |
How Found scored, category by category
Each line below comes from Found’s own pages, read November 20, 2026, scored against the published v4.1 scoring guide. Total: 75 of 100, rank 3 of 10.
| Category | Points | What we found |
|---|---|---|
| Pricing transparency | 20 of 20 | Every plan length priced per 28-day cycle with medication included; “Same price every dose” on the semaglutide page; no conflicting figures. |
| Total annual cost | 17 of 20 | $1,937: 13 cycles of $149 on the 12-month cash term for semaglutide (28-day cycles mean 13 charges a year, not 12). |
| Clinical oversight | 12 of 15 | A board-certified clinician reviews each case (5) and monthly clinician check-ins are described (5); prescribers are named only as Found-affiliated clinicians (2 of 5). |
| Pharmacy transparency | 9 of 15 | “Licensed 503A compounding pharmacies located in the United States”: license type stated (5 of 5), no pharmacy named (4 of 10). |
| Support | 5 of 10 | Member support by chat, hours not stated (3); between visits an AI companion and a community, with no human coaching described (2 of 5). |
| Regulatory disclosure | 7 of 10 | The FDA status appears only in a footnote: “Compounded GLP-1s are not FDA- approved or evaluated for safety or efficacy” (3 of 6); no FDA warning letter found (4). |
| Accessibility | 5 of 10 | The same footnote says compounded GLP-1s are “not available in all states”, with no list (1 of 4); HSA/FSA and insurance (3); cancellation terms sit behind a refund-policy link (1 of 3). |
| Total | 75 of 100 | Rank 3 of the 10 GLP-1 programs scored on November 20, 2026 (ties ordered by annual-cost points). |
What we verified on November 20, 2026
We read Found’s compounded semaglutide and tirzepatide store pages on November 20, 2026. Cash-pay prices fell since October 15 for tirzepatide ($359 to $339 month to month; $239 to $199 per cycle on 12 months; first cycle $219 to $199). The insurance track ($79 first month, then from $79 per cycle for semaglutide) needs in-network coverage and a video visit billed at your copay, so we scored the cash track. We did not enroll, so we could not see intake-only fees, the pharmacy that fills each order or any price that appears only after checkout.
Five checks before you enroll
- The prescriber. Look up the clinician’s name in the NPPES NPI Registry and on your state medical or nursing board site.
- The pharmacy. Ask which pharmacy fills the prescription and check its license with your state board of pharmacy (FDA’s BeSafeRx links to each board).
- The 12-month total. Add the program or membership fee, the medication at your expected maintenance dose and shipping, then multiply by 12 (by 13 for 28-day cycles).
- The exit terms. Read the cancellation and refund rules before the first charge.
- The drug itself. Ask whether you will get an FDA-approved brand product or a compounded preparation. Compounded semaglutide and tirzepatide are not FDA-approved and are not generics.
How Found compares with NexLife
NexLife, the highest-scoring GLP-1 program at 86/100 on the v4.1 methodology, publishes compounded semaglutide at $95 a month and tirzepatide at $115 a month on 12-month plans ($109 and $129 month to month), the same price at every dose with no membership. It lost points for an open FDA warning letter (730096, June 8, 2026) and for conflicting price, state and pharmacy statements on its own pages. Price check: month to month, Mondae lists $126 for tirzepatide and $87 for semaglutide, and Eden Health $99 for semaglutide (read November 20, 2026). Our NexLife vs Found comparison sets the two side by side.
Related reading
Sources
- Found compounded semaglutide store page, read November 20, 2026.
- Found compounded tirzepatide store page, read November 20, 2026.
- Our v4.1 scoring guide, published November 20, 2026.
GLP-1 program scores use the v4.1 methodology and pages read November 20, 2026; peptide and hormone clinics keep their May 2026 profiles and are not part of that ranking.